Why the study?
Simultaneous acute ischemic stroke and STEMI (cardio-cerebral infarction) represents a challenging emergency with competing therapeutic priorities, and no clear guidelines currently exist to guide management.
Population
One 63-year-old male with simultaneous acute ischemic stroke and inferior STEMI
Design
Case report
Follow-up
One month
Key result
Conservative medical therapy with deferred coronary revascularization improved NIHSS from 17 to 10 and achieved successful PCI after one month in a 63-year-old male with simultaneous acute ischemic stroke and STEMI.
Authors
Loading...
Supports stroke-first conservative care with deferred PCI in high-bleeding-risk cases; leaves open broader validation via dedicated trials.
Case Report (n=1)
No
In patients with simultaneous STEMI and acute ischemic stroke with high hemorrhagic risk, a stroke-first conservative approach followed by deferred PCI may be a safe and effective strategy.
Daoudi et al. (2026) conducted a case report in 63-year-old male with concurrent acute ischemic stroke (right MCA territory infarction, NIHSS 17) and inferior ST-elevation myocardial infarction (STEMI) with atrial fibrillation (n=1). Conservative medical therapy with aspirin (75 mg/day) and intermediate-dose low-molecular-weight heparin (enoxaparin 40 mg BID) followed by delayed percutaneous coronary intervention (PCI) with 3 stents after one month was evaluated on Neurological improvement measured by NIH Stroke Scale (NIHSS) and functional outcome by modified Rankin Score (mRS); coronary artery patency and clinical stability. Conservative medical therapy with deferred coronary revascularization improved NIHSS from 17 to 10 and achieved successful PCI after one month in a 63-year-old male with simultaneous acute ischemic stroke and STEMI.